Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1985
Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvariaA H Tashjian, E F Voelkel, M Lazzaro, et al.
Kidney International|May 1, 1983
Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalaciaJ A Kraut, J H Shinaberger, F R Singer, et al.
American Journal of Human Genetics|August 27, 1998
Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of boneM J Nellissery, S S Padalecki, Z Brkanac, et al.
The Journal of Clinical Investigation|December 1, 1991
Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferationT Hongo, J Kupfer, H Enomoto, et al.
The American Journal of Medicine|March 1, 1983
Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalaciaA B Hodsman, E G Wong, D J Sherrard, et al.
The Journal of Clinical Investigation|June 23, 2000
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of boneC Menaa, S V Reddy, N Kurihara, et al.
Annals of Internal Medicine|May 1, 1981
Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidismA B Hodsman, D J Sherrard, E G Wong, et al.
Human Molecular Genetics|December 14, 2001
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel geneE Cleiren, O Bénichou, E Van Hul, et al.
The American Journal of Medicine|August 1, 1995
Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodelingC H Chesnut, M R McClung, K E Ensrud, et al.
The American Journal of Medicine|November 14, 1997
Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal womenJ L Stock, N H Bell, C H Chesnut, et al.
Pageof 18